— Know what they know.
Not Investment Advice

DERM NASDAQ

Journey Medical Corporation
1W: -2.2% 1M: +23.2% 3M: -26.9% YTD: -16.6% 1Y: -9.7% 3Y: +314.0%
$5.96
-0.25 (-4.03%)
 
Weekly Expected Move ±12.6%
$5 $6 $6 $7 $8
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 59 · $164.0M mcap · 15M float · 1.72% daily turnover · Short 37% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -63.6%  ·  5Y Avg: 86.9%
Cost Advantage ★
50
Intangibles
35
Switching Cost
39
Network Effect
34
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DERM has No discernible competitive edge (38.9/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -63.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$13
Avg Target
$13
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$13.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-08-25 H.C. Wainwright Brandon Folkes Initiated $13 +75.7% $7.40
2025-03-27 Industrial Alliance Securities Initiated $10 +77.4% $5.92

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DERM receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-13 C- D+
2026-04-24 D+ C-
2026-04-16 C- D+
2026-04-13 D+ C-
2026-04-01 C- D+
2026-03-26 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

23 Grade D
Profitability
16
Balance Sheet
60
Earnings Quality
51
Growth
51
Value
19
Momentum
50
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DERM scores highest in Balance Sheet (60/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.61
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-1.07
Possible Manipulator
Ohlson O-Score
-4.44
Bankruptcy prob: 1.2%
Low Risk
Credit Rating
B+
Score: 33.0/100
Trend: Improving
Earnings Quality
OCF/NI: 0.71x
Accruals: -3.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DERM scores 0.61, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DERM scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DERM's score of -1.07 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DERM's implied 1.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DERM receives an estimated rating of B+ (score: 33.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-16.97x
PEG
1.53x
P/S
2.54x
P/B
5.28x
P/FCF
-18.90x
P/OCF
EV/EBITDA
-60.34x
EV/Revenue
1.61x
EV/EBIT
-17.03x
EV/FCF
-15.36x
Earnings Yield
-7.49%
FCF Yield
-5.29%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. DERM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.006
NI / EBT
×
Interest Burden
1.559
EBT / EBIT
×
EBIT Margin
-0.094
EBIT / Rev
×
Asset Turnover
0.740
Rev / Assets
×
Equity Multiplier
3.367
Assets / Equity
=
ROE
-36.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DERM's ROE of -36.9% is driven by financial leverage (equity multiplier: 3.37x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1135 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.96
Median 1Y
$3.56
5th Pctile
$0.79
95th Pctile
$16.01
Ann. Volatility
89.9%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Claude Maraoui
President and Chief Executive Officer
$583,495 $310,938 $1,665,876
Ramsey Alloush Operating
rating Officer, Corporate Secretary and General Counsel
$392,945 $295,706 $1,194,192
Joseph Benesch Financial
ancial Officer
$318,270 $182,403 $823,673

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,665,876
Avg Employee Cost (SGA/emp): $764,966
Employees: 58

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
58
+41.5% YoY
Revenue / Employee
$1,066,517
Rev: $61,858,000
Profit / Employee
$-197,086
NI: $-11,431,000
SGA / Employee
$764,966
Avg labor cost proxy
R&D / Employee
$8,276
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -51.7% -55.0% -72.9% -96.9% -1.0% -1.3% -1.3% -41.9% -20.6% -22.3% 4.5% -98.2% -72.6% -41.1% -43.2% -42.9% -44.0% -36.9% -36.93%
ROA -22.4% -23.8% -31.5% -41.9% -29.3% -37.9% -38.7% -12.2% -4.2% -4.6% 0.9% -20.1% -18.7% -10.6% -11.1% -11.0% -13.1% -11.0% -10.97%
ROIC 1.2% 1.3% 2.2% 3.4% -2.7% -3.6% -3.6% -99.1% -15.4% -19.3% 15.8% -1.3% -42.4% -21.4% -21.3% -17.0% -81.9% -63.6% -63.55%
ROCE -14.8% -16.7% -32.4% -53.2% -71.9% -94.3% -95.5% -26.0% -5.5% -6.7% 7.1% -46.6% -26.4% -11.5% -11.5% -11.0% -13.7% -10.7% -10.70%
Gross Margin 58.8% 64.8% 58.3% 55.2% 51.7% 47.2% 54.8% 81.4% 60.6% 47.7% 56.0% 63.9% 83.6% 63.5% 60.0% 67.4% 59.5% 54.0% 53.99%
Operating Margin -51.7% -3.8% -39.0% -58.9% -62.6% -78.3% -44.6% 49.9% -13.8% -77.4% -19.7% -19.8% 16.4% -25.3% -19.2% -8.7% -2.8% -9.3% -9.35%
Net Margin -1.2% -5.9% -41.2% -62.5% -66.7% -83.0% -48.7% 48.6% -14.0% -80.1% -22.6% -16.3% 11.2% -31.0% -25.3% -13.1% -7.8% -14.0% -13.97%
EBITDA Margin -35.8% 0.7% -33.3% -52.6% -54.9% -68.7% -38.0% 52.1% -7.6% -69.5% -13.2% -5.4% 25.1% -16.0% -11.4% -1.8% 4.0% -2.1% -2.15%
FCF Margin -25.2% -57.6% -45.4% -45.3% -72.7% -64.5% -53.9% -8.9% 6.7% 7.8% -3.7% -39.4% -16.3% -12.3% -4.8% -6.6% -20.2% -10.5% -10.47%
OCF Margin -18.3% -5.7% -9.5% -17.2% -18.4% -24.6% -13.2% 22.4% 6.6% 1.5% -10.3% -48.2% -16.3% -12.3% -4.8% -6.6% -20.2% -10.5% -10.47%
ROE 3Y Avg snapshot only -30.64%
ROE 5Y Avg snapshot only -74.59%
ROA 3Y Avg snapshot only -8.63%
ROIC Economic snapshot only -16.33%
Cash ROA snapshot only -7.16%
Cash ROIC snapshot only -85.97%
CROIC snapshot only -85.97%
NOPAT Margin snapshot only -7.74%
Pretax Margin snapshot only -14.73%
R&D / Revenue snapshot only 0.68%
SGA / Revenue snapshot only 49.25%
SBC / Revenue snapshot only 4.93%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -3.28 -3.62 -2.13 -1.06 -1.15 -0.73 -0.73 -4.67 -28.89 -17.48 133.77 -6.33 -5.90 -16.07 -19.14 -20.51 -16.52 -13.36 -16.973
P/S Ratio 4.07 2.05 1.10 0.58 0.46 0.45 0.47 0.72 1.41 0.91 1.45 2.01 1.54 2.37 2.97 2.99 3.05 1.98 2.536
P/B Ratio 1.69 1.99 1.55 1.03 2.00 1.65 1.69 3.39 5.47 3.57 5.54 5.70 4.32 6.65 8.33 8.85 5.93 4.02 5.278
P/FCF -16.17 -3.56 -2.43 -1.27 -0.64 -0.69 -0.86 -8.15 20.88 11.60 -39.20 -5.09 -9.49 -19.22 -61.80 -45.20 -15.09 -18.90 -18.902
P/OCF 3.22 21.24 61.77
EV/EBITDA -3.68 -5.80 -1.40 0.23 -1.08 -0.60 -0.61 -8.54 52.89 50.08 17.72 -8.20 -10.96 -96.80 -145.31 -258.99 -47.41 -60.34 -60.342
EV/Revenue 1.32 0.87 0.29 -0.06 0.34 0.30 0.32 0.61 1.28 0.79 1.33 1.84 1.64 2.47 3.06 3.08 2.67 1.61 1.609
EV/EBIT -3.42 -4.64 -1.16 0.20 -0.91 -0.52 -0.54 -4.88 -52.53 -26.90 41.77 -6.52 -7.73 -26.70 -33.20 -37.02 -21.14 -17.03 -17.030
EV/FCF -5.24 -1.51 -0.64 0.14 -0.47 -0.47 -0.59 -6.87 19.06 10.05 -35.82 -4.67 -10.08 -20.00 -63.79 -46.57 -13.18 -15.36 -15.364
Earnings Yield -30.5% -27.7% -47.0% -94.0% -87.0% -1.4% -1.4% -21.4% -3.5% -5.7% 0.7% -15.8% -16.9% -6.2% -5.2% -4.9% -6.1% -7.5% -7.49%
FCF Yield -6.2% -28.1% -41.1% -78.7% -1.6% -1.4% -1.2% -12.3% 4.8% 8.6% -2.6% -19.6% -10.5% -5.2% -1.6% -2.2% -6.6% -5.3% -5.29%
PEG Ratio snapshot only 1.532
Price/Tangible Book snapshot only 30.153
EV/Gross Profit snapshot only 2.664
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.64 1.64 1.64 1.64 1.16 1.16 1.16 1.16 1.35 1.35 1.35 1.35 1.37 1.37 1.37 1.37 1.79 1.79 1.786
Quick Ratio 1.45 1.45 1.45 1.45 0.95 0.95 0.95 0.95 1.10 1.10 1.10 1.10 0.96 0.96 0.96 0.96 1.53 1.53 1.529
Debt/Equity 0.02 0.02 0.02 0.02 1.35 1.35 1.35 1.35 0.87 0.87 0.87 0.87 1.28 1.28 1.28 1.28 0.00 0.00 0.004
Net Debt/Equity -1.15 -1.15 -1.15 -1.15 -0.53 -0.53 -0.53 -0.53 -0.48 -0.48 -0.48 -0.48 0.27 0.27 0.27 0.27 -0.75 -0.75 -0.753
Debt/Assets 0.01 0.01 0.01 0.01 0.22 0.22 0.22 0.22 0.23 0.23 0.23 0.23 0.32 0.32 0.32 0.32 0.00 0.00 0.001
Debt/EBITDA -0.15 -0.15 -0.07 -0.04 -0.99 -0.72 -0.71 -4.04 9.23 14.09 3.05 -1.37 -3.06 -17.93 -21.64 -36.36 -0.03 -0.07 -0.069
Net Debt/EBITDA 7.69 7.88 3.94 2.33 0.39 0.28 0.28 1.59 -5.05 -7.72 -1.67 0.75 -0.64 -3.77 -4.55 -7.64 6.89 13.90 13.896
Interest Coverage -1.65 -1.70 -2.99 -4.42 -13.64 -15.85 -14.18 -4.34 -1.14 -1.47 1.76 -8.62 -4.41 -1.71 -1.52 -1.38 -2.11 -1.65 -1.652
Equity Multiplier 2.31 2.31 2.31 2.31 6.19 6.19 6.19 6.19 3.78 3.78 3.78 3.78 4.00 4.00 4.00 4.00 2.97 2.97 2.970
Cash Ratio snapshot only 0.643
Debt Service Coverage snapshot only -0.466
Cash to Debt snapshot only 202.437
FCF to Debt snapshot only -56.933
Defensive Interval snapshot only 433.0 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.18 0.42 0.61 0.77 0.73 0.62 0.61 0.79 0.87 0.88 0.85 0.63 0.71 0.72 0.72 0.76 0.71 0.74 0.740
Inventory Turnover 0.73 1.56 2.34 3.07 2.56 2.42 2.43 2.36 2.19 2.22 2.12 2.02 1.69 1.53 1.49 1.52 1.92 2.13 2.129
Receivables Turnover 0.76 1.77 2.56 3.25 2.87 2.44 2.40 3.11 3.65 3.68 3.58 2.66 4.41 4.42 4.43 4.67 3.09 3.23 3.233
Payables Turnover 0.32 0.68 1.01 1.33 1.03 0.97 0.98 0.95 1.00 1.02 0.97 0.93 1.30 1.17 1.14 1.17 1.82 2.02 2.020
DSO 482 207 143 112 127 150 152 117 100 99 102 137 83 83 82 78 118 113 112.9 days
DIO 498 233 156 119 142 151 150 155 167 165 172 180 215 238 245 239 190 171 171.4 days
DPO 1152 540 361 275 355 376 374 385 363 358 375 393 281 311 320 312 201 181 180.7 days
Cash Conversion Cycle -173 -100 -62 -44 -85 -75 -72 -113 -96 -95 -101 -75 17 10 8 5 108 104 103.6 days
Fixed Asset Turnover snapshot only 582.703
Operating Cycle snapshot only 284.3 days
Cash Velocity snapshot only 2.685
Capital Intensity snapshot only 1.462
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.2% 53.3% 4.0% 6.2% 7.5% 27.8% 26.4% -27.7% -29.1% -29.7% -27.4% 2.8% 10.2% 15.0% 15.00%
Net Income -36.2% -66.0% -27.9% 69.7% 87.0% 89.2% 1.0% -48.4% -2.8% -99.6% -11.4% 52.8% 22.1% -15.5% -15.48%
EPS -1.8% -61.4% -24.0% 74.6% 88.1% 90.2% 1.0% -52.0% -2.3% -74.4% -9.9% 61.1% 29.5% 4.4% 4.38%
FCF -11.2% -71.6% -23.4% 79.3% 1.1% 1.2% 91.3% -2.2% -2.7% -2.1% 5.9% 82.7% -37.1% 2.4% 2.38%
EBITDA -2.7% -4.2% -1.6% 72.5% 1.1% 1.0% 1.2% -1.3% -5.4% -2.1% -1.2% 94.5% 58.6% -20.3% -20.29%
Op. Income -2.0% -2.6% -1.1% 62.5% 92.5% 92.8% 1.1% -80.8% -5.6% -1.7% -4.2% 69.5% 40.3% 8.3% 8.26%
OCF Growth snapshot only 2.38%
Asset Growth snapshot only 17.88%
Equity Growth snapshot only 58.71%
Debt Growth snapshot only -99.54%
Shares Change snapshot only 20.76%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 47.4% 11.3% -1.6% -7.6% -5.7% 1.1% 1.10%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 50.7% 13.8% 1.9% -3.3% -3.3% 5.2% 5.20%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -6.2% -6.2% -6.2% -6.2% -3.5% -3.5% -3.47%
Assets 5Y
Equity 3Y -21.8% -21.8% -21.8% -21.8% 23.3% 23.3% 23.32%
Book Value 3Y -34.2% -28.5% -29.0% -30.4% 10.7% 6.9% 6.95%
Dividend 3Y
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.82 1.00 0.84 0.56 0.32 0.26 0.01 0.65 0.51 0.05 0.050
Earnings Stability 0.46 0.31 0.56 0.56 0.31 0.43 0.54 0.66 0.33 0.41 0.414
Margin Stability 0.93 0.89 0.88 0.94 0.94 0.90 0.89 0.92 0.95 0.90 0.902
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.20 0.81 0.50 0.50 0.20 0.50 0.91 0.94 0.938
Earnings Smoothness
ROE Trend 0.94 1.20 1.56 -0.05 0.24 0.82 0.70 0.38 0.10 0.01 0.008
Gross Margin Trend 0.08 0.08 0.10 -0.05 0.01 0.07 0.08 0.07 -0.02 -0.06 -0.059
FCF Margin Trend 0.56 0.69 0.46 -0.12 0.17 0.16 0.24 0.18 -0.15 -0.08 -0.082
Sustainable Growth Rate 4.5%
Internal Growth Rate 0.9%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.15 0.10 0.18 0.32 0.46 0.40 0.21 -1.45 -1.36 -0.28 -9.45 1.52 0.62 0.84 0.31 0.45 1.09 0.71 0.707
FCF/OCF 1.37 10.13 4.77 2.64 3.96 2.63 4.08 -0.39 1.02 5.33 0.36 0.82 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.707
CapEx/Revenue 6.9% 51.9% 35.9% 28.2% 54.3% 39.9% 40.7% 31.3% 0.0% 6.3% 6.4% 8.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.19 -0.21 -0.26 -0.29 -0.16 -0.23 -0.31 -0.30 -0.10 -0.06 0.10 0.10 -0.07 -0.02 -0.08 -0.06 0.01 -0.03 -0.032
Sloan Accruals snapshot only 0.138
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio 0.0% 0.0%
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 2.2% 2.3% 2.9% 4.4% 1.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -43.5% -36.2% -46.5% -70.0% 0.3% -0.4% -0.0% -0.0% -4.1% -8.4% -5.4% -5.4% -9.2% -8.0% -6.5% -10.0% -9.0% -10.1% -10.09%
Total Shareholder Return -43.5% -36.2% -46.5% -70.0% 0.3% -0.4% -0.0% -0.0% -4.1% -8.4% -5.4% -5.4% -9.2% -8.0% -6.5% -10.0% -9.0% -10.1% -10.09%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.62 1.57 1.38 1.26 1.00 1.00 1.00 1.01 1.06 1.06 0.79 1.01 1.00 1.01 1.01 1.01 1.01 1.01 1.006
Interest Burden (EBT/EBIT) 1.99 1.92 1.51 1.33 1.07 1.06 1.07 1.23 1.88 1.68 0.43 1.12 1.23 1.59 1.66 1.73 1.46 1.56 1.559
EBIT Margin -0.39 -0.19 -0.25 -0.32 -0.37 -0.58 -0.60 -0.12 -0.02 -0.03 0.03 -0.28 -0.21 -0.09 -0.09 -0.08 -0.13 -0.09 -0.094
Asset Turnover 0.18 0.42 0.61 0.77 0.73 0.62 0.61 0.79 0.87 0.88 0.85 0.63 0.71 0.72 0.72 0.76 0.71 0.74 0.740
Equity Multiplier 2.31 2.31 2.31 2.31 3.43 3.43 3.43 3.43 4.88 4.88 4.88 4.88 3.89 3.89 3.89 3.89 3.37 3.37 3.367
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.64 $-1.34 $-1.76 $-2.31 $-1.67 $-2.16 $-2.18 $-0.59 $-0.20 $-0.21 $0.04 $-0.89 $-0.66 $-0.37 $-0.38 $-0.35 $-0.47 $-0.35 $-0.35
Book Value/Share $3.17 $2.43 $2.41 $2.39 $0.96 $0.95 $0.94 $0.81 $1.05 $1.03 $1.02 $0.99 $0.91 $0.89 $0.86 $0.80 $1.30 $1.17 $1.13
Tangible Book/Share $2.23 $1.70 $1.69 $1.67 $-0.58 $-0.57 $-0.57 $-0.49 $0.00 $0.00 $0.00 $0.00 $-0.53 $-0.52 $-0.51 $-0.47 $0.17 $0.16 $0.16
Revenue/Share $1.32 $2.36 $3.39 $4.27 $4.16 $3.51 $3.41 $3.80 $4.10 $4.05 $3.89 $2.81 $2.53 $2.49 $2.42 $2.38 $2.53 $2.37 $2.37
FCF/Share $-0.33 $-1.36 $-1.54 $-1.94 $-3.02 $-2.27 $-1.84 $-0.34 $0.28 $0.32 $-0.14 $-1.11 $-0.41 $-0.31 $-0.12 $-0.16 $-0.51 $-0.25 $-0.25
OCF/Share $-0.24 $-0.13 $-0.32 $-0.73 $-0.76 $-0.86 $-0.45 $0.85 $0.27 $0.06 $-0.40 $-1.36 $-0.41 $-0.31 $-0.12 $-0.16 $-0.51 $-0.25 $-0.25
Cash/Share $3.71 $2.83 $2.81 $2.79 $1.81 $1.80 $1.78 $1.52 $1.42 $1.39 $1.37 $1.34 $0.92 $0.90 $0.87 $0.81 $0.98 $0.88 $1.00
EBITDA/Share $-0.47 $-0.35 $-0.70 $-1.17 $-1.31 $-1.78 $-1.79 $-0.27 $0.10 $0.06 $0.29 $-0.63 $-0.38 $-0.06 $-0.05 $-0.03 $-0.14 $-0.06 $-0.06
Debt/Share $0.07 $0.05 $0.05 $0.05 $1.30 $1.29 $1.28 $1.09 $0.92 $0.90 $0.89 $0.86 $1.16 $1.14 $1.10 $1.03 $0.00 $0.00 $0.00
Net Debt/Share $-3.64 $-2.78 $-2.76 $-2.73 $-0.51 $-0.51 $-0.50 $-0.43 $-0.50 $-0.49 $-0.49 $-0.47 $0.24 $0.24 $0.23 $0.22 $-0.98 $-0.88 $-0.88
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.611
Altman Z-Prime snapshot only 0.357
Piotroski F-Score 2 2 2 2 3 3 2 6 6 6 5 2 4 4 4 6 4 4 4
Beneish M-Score -2.47 -2.21 -3.16 -2.82 -3.62 -3.25 -2.53 -2.49 -3.08 -2.82 -2.97 -2.62 -0.73 -1.07 -1.070
Ohlson O-Score snapshot only -4.437
ROIC (Greenblatt) snapshot only -20.69%
Net-Net WC snapshot only $0.15
EVA snapshot only $-5796700.00
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B+
Credit Score 33.22 33.61 33.93 34.51 21.32 20.90 20.71 29.36 28.68 27.18 37.91 29.28 22.06 26.05 25.49 25.06 34.28 32.96 32.959
Credit Grade snapshot only 14
Credit Trend snapshot only 6.909
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 22
Sector Credit Rank snapshot only 24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms